Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients

Journal of Thrombosis and Haemostasis

Volumn 13, Issue 10, 2015, Pages 1878-1887

  Moore, H B ^a,b   Moore, E E ^a,b   Chapman, M P ^a,b   Gonzalez, E ^a,b   Slaughter, A L ^a,b   Morton, A P ^a,b   D'Alessandro, A ^a   Hansen, K C ^a   Sauaia, A ^a   Banerjee, A ^a   Silliman, C C ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

^c Bonfils Blood Center   (United States)

Author keywords

Blood platelet disorder; Fibrinogen; Fibrinolysis; Platelet function tests; Trauma

Indexed keywords

ADENOSINE DIPHOSPHATE; CALCIUM; FIBRINOGEN; GLYCOCHOLIC ACID; LACTIC ACID; SPERMIDINE; SPERMINE; SUCCINIC ACID; TISSUE PLASMINOGEN ACTIVATOR; BIOLOGICAL MARKER; FIBRINOLYTIC AGENT;

ADULT; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HUMAN; INJURY SCALE; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY; VISCOELASTICITY; BLOOD; BLOOD CLOTTING PARAMETERS; BLOOD VISCOSITY; DRUG EFFECTS; ELASTICITY; FIBRINOLYTIC THERAPY; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PREDICTIVE VALUE; PROCEDURES; STATISTICAL MODEL; THROMBOCYTE; TREATMENT OUTCOME; WOUNDS AND INJURIES;

ADENOSINE DIPHOSPHATE; ADULT; BIOMARKERS; BLOOD PLATELETS; BLOOD VISCOSITY; CALCIUM; ELASTICITY; FEMALE; FIBRINOGEN; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HUMANS; INJURY SEVERITY SCORE; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 84942908284     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.13067     Document Type: Article

References (60)

1. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, Pons PT. Epidemiology of trauma deaths: a reassessment. J Trauma 1995; 38: 185-93.
2. Tisherman SA, Schmicker RH, Brasel KJ, Bulger EM, Kerby JD, Minei JP, Powell JL, Reiff DA, Rizoli SB, Schreiber MA. Detailed description of all deaths in both the shock and traumatic brain injury hypertonic saline trials of the Resuscitation Outcomes Consortium. Ann Surg 2015; 261: 586-90.
3. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003; 54: 1127-30.
4. Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, Pittet JF. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008; 64: 1211-17; discussion 7.
5. Ostrowski SR, Johansson PI. Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy. J Trauma Acute Care Surg 2012; 73: 60-6.
6. Schlimp CJ, Schochl H. The role of fibrinogen in trauma-induced coagulopathy. Hamostaseologie 2013; 34: 29-39.
7. Wohlauer MV, Moore EE, Thomas S, Sauaia A, Evans E, Harr J, Silliman CC, Ploplis V, Castellino FJ, Walsh M. Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma. J Am Coll Surg 2012; 214: 739-46.
8. Kashuk JL, Moore EE, Sawyer M, Wohlauer M, Pezold M, Barnett C, Biffl WL, Burlew CC, Johnson JL, Sauaia A. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg 2010; 252: 434-42; discussion 43-4.
9. Cotton BA, Harvin JA, Kostousouv V, Minei KM, Radwan ZA, Schochl H, Wade CE, Holcomb JB, Matijevic N. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg 2012; 73: 365-70; discussion 70.
10. Moore HB, Moore EE, Gonzalez E, Chapman MP, Chin TL, Silliman CC, Banerjee A, Sauaia A. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg 2014; 77: 811-17; discussion 7.
11. Ives C, Inaba K, Branco BC, Okoye O, Schochl H, Talving P, Lam L, Shulman I, Nelson J, Demetriades D. Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma. J Am Coll Surg 2012; 215: 496-502.
12. Cardenas JC, Matijevic N, Baer LA, Holcomb JB, Cotton BA, Wade CE. Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients. Shock 2014; 41: 514-21.
13. Booth NA. Fibrinolysis and thrombosis. Bailliere's Best Pract Res Clin Haematol 1999; 12: 423-33.
14. Moore HB, Moore EE, Gonzalez E, Wiener G, Chapman MP, Dzieciatkowska M, Sauaia A, Banerjee A, Hansen KC, Silliman C. Plasma is the physiologic buffer of tissue plasminogen activator-mediated fibrinolysis: rationale for plasma-first resuscitation after life-threatening hemorrhage. J Am Coll Surg 2015; 220: 872-9.
15. Bennett B, Croll A, Ferguson K, Booth NA. Complexing of tissue plasminogen activator with PAI-1, alpha 2-macroglobulin, and C1-inhibitor: studies in patients with defibrination and a fibrinolytic state after electroshock or complicated labor. Blood 1990; 75: 671-6.
16. Mutch NJ, Koikkalainen JS, Fraser SR, Duthie KM, Griffin M, Mitchell J, Watson HG, Booth NA. Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis. J Thromb Haemost 2010; 8: 2017-24.
17. Bouma BN, Mosnier LO. Thrombin activatable fibrinolysis inhibitor (TAFI) - how does thrombin regulate fibrinolysis? Ann Med 2006; 38: 378-88.
18. Moore HB, Moore EE, Gonzalez E, Hansen KC, Dzieciatkowska M, Chapman MP, Sauaia A, West B, Banerjee A, Silliman CC. Hemolysis exacerbates hyperfibrinolysis, whereas platelolysis shuts down fibrinolysis: evolving concepts of the spectrum of fibrinolysis in response to severe injury. Shock 2015; 43: 39-46.
19. Dirkmann D, Gorlinger K, Gisbertz C, Dusse F, Peters J. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood. Anest Analg 2012; 114: 1182-8.
20. Harr JN, Moore EE, Ghasabyan A, Chin TL, Sauaia A, Banerjee A, Silliman CC. Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma. Shock 2013; 39: 45-9.
21. Castellino FJ, Chapman MP, Donahue DL, Thomas S, Moore EE, Wohlauer MV, Fritz B, Yount R, Ploplis V, Davis P, Evans E, Walsh M. Traumatic brain injury causes platelet adenosine diphosphate and arachidonic acid receptor inhibition independent of hemorrhagic shock in humans and rats. J Trauma Acute Care Surg 2014; 76: 1169-76.
22. D'Alessandro A, Moore HB, Moore EE, Wither M, Nemkov T, Gonzalez E, Slaughter A, Fragosis M, Hansen KC, Silliman CC, Banerjee A. Early hemorrhage triggers metabolic responses that build up during prolonged shock. Am J Physiol Regul 2015; 308: 1034-44.
23. D'Alessandro A, Nemkov T, Kelher M, West FB, Schwindt RK, Banerjee A, Moore EE, Silliman CC, Hansen KC. Routine storage of red blood cell (RBC) units in additive solution-3: a comprehensive investigation of the RBC metabolome. Transfusion 2015; 55: 1034-44.
24. Wiener G, Moore HB, Moore EE, Gonzalez E, Diamond S, Zhu S, D'Alessandro A, Banerjee A. Shock releases bile acid inducing platelet inhibition and fibrinolysis. J Surg Res 2015; 195: 390-5.
25. Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinolysis 2001; 12: 327-37.
26. Chapman MP, Moore EE, Ramos CR, Ghasabyan A, Harr JN, Chin TL, Stringham JR, Sauaia A, Silliman CC, Banerjee A. Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy. J Trauma Acute Care Surg 2013; 75: 961-7.
27. Moore HB, Moore EE, Lawson PJ, Gonzalez E, Fragoso M, Morton AP, Gamboni F, Chapman MP, Sauaia A, Banerjee A, Silliman CC. Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shock. Surgery 2015; 158: 386-92.
28. Chin TL, Moore EE, Coors ME, Chandler JG, Ghasabyan A, Harr JN, Stringham JR, Ramos CR, Ammons S, Banerjee A, Sauaia A. Exploring ethical conflicts in emergency trauma research: the COMBAT (Control of Major Bleeding after Trauma) study experience. Surgery 2015; 157: 10-19.
29. Kutcher ME, Ferguson AR, Cohen MJ. A principal component analysis of coagulation after trauma. J Trauma Acute Care Surg 2013; 74: 1223-9; discussion 9-30.
30. Duan K, Yu W, Lin Z, Tan S, Bai X, Xu L, Dong Y, Li N. A time course study of acute traumatic coagulopathy prior to resuscitation: from hypercoagulation to hypocoagulation caused by hypoperfusion? Transfus Apher Sci 2014; 50: 399-406.
31. Prat NJ, Montgomery R, Cap AP, Dubick MA, Sarron JC, Destombe C, May P, Magnan P. Comprehensive evaluation of coagulation in swine subjected to isolated primary blast injury. Shock 2015; 43: 598-603.
32. Schreiber MA, Differding J, Thorborg P, Mayberry JC, Mullins RJ. Hypercoagulability is most prevalent early after injury and in female patients. J Trauma 2005; 58: 475-80; discussion 80-1.
33. Muller MC, Balvers K, Binnekade JM, Curry N, Stanworth S, Gaarder C, Kolstadbraaten KM, Rourke C, Brohi K, Goslings JC, Juffermans NP. Thromboelastometry and organ failure in trauma patients: a prospective cohort study. Crit Care 2014; 18: 687-94.
34. Deras P, Villiet M, Manzanera J, Latry P, Schved JF, Capdevila X, Charbit J. Early coagulopathy at hospital admission predicts initial or delayed fibrinogen deficit in severe trauma patients. J Trauma Acute Care Surg 2014; 77: 433-40.
35. Schlimp CJ, Solomon C, Ranucci M, Hochleitner G, Redl H, Schochl H. The effectiveness of different functional fibrinogen polymerization assays in eliminating platelet contribution to clot strength in thromboelastometry. Anesth Analg 2014; 118: 269-76.
36. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 2007; 245: 812-18.
37. Schochl H, Cadamuro J, Seidl S, Franz A, Solomon C, Schlimp CJ, Ziegler B. Hyperfibrinolysis is common in out-of-hospital cardiac arrest: results from a prospective observational thromboelastometry study. Resuscitation 2013; 84: 454-9.
38. Hoffman M, Monroe DM 3rd. A cell-based model of hemostasis. Thromb Haemost 2001; 85: 958-65.
39. Stalker TJ, Traxler EA, Wu J, Wannemacher KM, Cermignano SL, Voronov R, Diamond SL, Brass LF. Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network. Blood 2013; 121: 1875-85.
40. Brass LF, Zhu L, Stalker TJ. Minding the gaps to promote thrombus growth and stability. J Clin Invest 2005; 115: 3385-92.
41. Brass LF, Stalker TJ. Minding the gaps - and the junctions, too. Circulation 2012; 125: 2414-16.
42. Colace TV, Fogarty PF, Panckeri KA, Li R, Diamond SL. Microfluidic assay of hemophilic blood clotting: distinct deficits in platelet and fibrin deposition at low factor levels. J Thromb Haemost 2014; 12: 147-58.
43. Muthard RW, Diamond SL. Blood clots are rapidly assembled hemodynamic sensors: flow arrest triggers intraluminal thrombus contraction. Arterioscler Thromb Vasc Biol 2012; 32: 2938-45.
44. Li Z, Delaney MK, O'Brien KA, Du X. Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol 2010; 30: 2341-9.
45. Mazepa M, Hoffman M, Monroe D. Superactivated platelets: thrombus regulators, thrombin generators, and potential clinical targets. Arterioscler Thromb Vasc Biol 2013; 33: 1747-52.
46. Peltz ED, D'Alessandro A, Moore EE, Chin T, Silliman CC, Sauaia A, Hansen KC, Banerjee A. Pathologic metabolism: an exploratory study of the plasma metabolome of critical injury. J Trauma Acute Care Surg 2015; 78: 742-51.
47. Pereira J, Accatino L, Pizarro M, Mezzano V, Ibanez A, Mezzano D. In vivo effect of bile salts on platelet aggregation in rats. Thromb Res 1995; 80: 357-62.
48. Shiao YJ, Chen JC, Wang CN, Wang CT. The mode of action of primary bile salts on human platelets. Biochim Biophys Acta 1993; 1146: 282-93.
49. de la Pena NC, Sosa-Melgarejo JA, Ramos RR, Mendez JD. Inhibition of platelet aggregation by putrescine, spermidine, and spermine in hypercholesterolemic rabbits. Arch Med Res 2000; 31: 546-50.
50. Mendez JD, Zarzoza E. Inhibition of platelet aggregation by L-arginine and polyamines in alloxan treated rats. Biochem Mol Biol Int 1997; 43: 311-18.
51. Martini WZ, Dubick MA, Wade CE, Holcomb JB. Evaluation of tris-hydroxymethylaminomethane on reversing coagulation abnormalities caused by acidosis in pigs. Crit Care Med 2007; 35: 1568-74.
52. Darlington DN, Kheirabadi BS, Delgado AV, Scherer MR, Martini WZ, Dubick MA. Coagulation changes to systemic acidosis and bicarbonate correction in swine. J Trauma 2011; 71: 1271-7.
53. Cohen MJ, Brohi K, Calfee CS, Rahn P, Chesebro BB, Christiaans SC, Carles M, Howard M, Pittet JF. Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit Care 2009; 13: R174.
54. Fink MP. Bench-to-bedside review: high-mobility group box 1 and critical illness. Crit Care 2007; 11: 229-36.
55. Ding N, Chen G, Hoffman R, Loughran PA, Sodhi CP, Hackam DJ, Billiar TR, Neal MD. Toll-like receptor 4 regulates platelet function and contributes to coagulation abnormality and organ injury in hemorrhagic shock and resuscitation. Circ Cardiovasc Genet 2014; 7: 615-24.
56. Solomon C, Traintinger S, Ziegler B, Hanke A, Rahe-Meyer N, Voelckel W, Schochl H. Platelet function following trauma. A multiple electrode aggregometry study. Thromb Haemost 2011; 106: 322-30.
57. Windelov NA, Sorensen AM, Perner A, Wanscher M, Larsen CF, Ostrowski SR, Johansson PI, Rasmussen LS. Platelet aggregation following trauma: a prospective study. Blood Coagul Fibrinolysis 2014; 25: 67-73.
58. Ellis TC, Nielsen VG, Marques MB, Kirklin JK. Thrombelastographic measures of clot propagation: a comparison of alpha with the maximum rate of thrombus generation. Blood Coagul Fibrinolysis 2007; 18: 45-8.
59. Darlington DN, Delgado AV, Kheirabadi BS, Fedyk CG, Scherer MR, Pusateri AE, Wade CE, Cap AP, Holcomb JB, Dubick MA. Effect of hemodilution on coagulation and recombinant factor VIIa efficacy in human blood in vitro. J Trauma 2011; 71: 1152-63.
60. Ostrowski SR, Haase N, Muller RB, Moller MH, Pott FC, Perner A, Johansson PI. Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: a prospective study. Crit Care 2015; 19: 191-200.